Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023

分子診断の世界市場予測(~2023年)

◆タイトル:Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023
◆商品コード:MD2521
◆調査・発行会社:MarketsandMarkets
◆発行日:2018年5月24日
◆ページ数:242
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single User(1名利用)USD5,650 ⇒換算¥638,450見積依頼/購入/質問フォーム
Multi User (Five User)USD6,650 ⇒換算¥751,450見積依頼/購入/質問フォーム
Corporate License (全社内共有可)USD8,150 ⇒換算¥920,950見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※ご購入後、レポートに記載の英語表現や単語の意味に関しましては無料でお答えいたします。(但し、対応範囲は弊社で判断)
※弊社H&Iグローバルリサーチ株式会社はMarketsandMarketsの日本における正規販売代理店です。

【レポートの概要】

MarketsandMarketsが発行した当調査レポートでは、分子診断の世界市場について調査・分析し、エグゼクティブサマリー、市場インサイト、市場概観/市場動向、市場シェア分析、用途(感染症、がん診断、遺伝子検査)別分析、技術別分析、需要先別分析、製品・サービス別分析、分子診断の世界市場規模及び予測、市場動向、競争状況、関連企業分析などの情報をお届けいたします。

“The global molecular diagnostics market is projected to grow at a CAGR of 8.4%.”The global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics, growth in the biomarker identification market, and advancements in molecular techniques. However, complex regulatory frameworks delaying the approval of new molecular diagnostic tests are expected to restrain the growth of this market during the forecast period.
“The reagents & kits segment to dominate the molecular diagnostics market, by product & service in 2018.”
Based on product and service, the molecular diagnostics market is segmented into reagents and kits, instruments, and services and software. The reagents and kits segment is expected to account for the largest share of the global molecular diagnostics market in 2018. The large share of this segment can be attributed to the availability of a wide range of reagents and kits, rising use of reagents and kits in different therapeutic areas (such as infectious diseases and oncology), increase in basic research and commercial applications, and easy accessibility to a wide range of reagents.
“The market in the Asia Pacific region is projected to register the highest CAGR during the forecast period.”
Asia Pacific is expected to register the highest CAGR in the global molecular diagnostics market during the forecast period. Market growth in the Asia Pacific is attributed to growing GDPs and a significant rise in disposable income levels, increased healthcare spending by a larger population base, modernization of healthcare infrastructure, and rising penetration of cutting-edge clinical laboratory technologies (especially in rural areas).
Break-up profile of primaries:
• By Company Type – Tier I: 40%, Tier II: 30%, and Tier III: 30%
• By Designation – C-level: 27%, D-level: 18%, and Others: 55%
• By Region – North America: 50%, Europe: 20%, Asia Pacific: 20%, and the RoW: 10%
The key players operating in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US).
Research coverage:
In this report, the molecular diagnostics market is segmented on the basis of product & service, application, technology, end user, and region. The study tracks and analyzes competitive developments such as product launches & approvals, acquisitions, collaborations, agreements, partnerships, and expansions, and core competencies in the molecular diagnostics market.

Reasons to buy this report:
The report provides insights on the following pointers:
Market Penetration: Comprehensive information on portfolios offered by the top players in the global molecular diagnostics market. The report analyzes the market, by product & service, application, technology, end user, and region
Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and product launches in the global molecular diagnostics market
Market Development: Comprehensive information about lucrative emerging markets—the report analyzes the markets for molecular diagnostic products across regions
Market Diversification: Exhaustive information about new products, untapped regions, and recent developments in the global molecular diagnostics market
Competitive Assessment: In-depth assessment of strategies, products, and manufacturing capabilities of the key players in the global molecular diagnostics market

【レポートの目次】

TABLE OF CONTENTS

1 INTRODUCTION 22
1.1 OBJECTIVES OF THE STUDY 22
1.2 MARKET DEFINITION 22
1.2.1 MARKETS COVERED 23
1.2.2 YEARS CONSIDERED FOR THE STUDY 24
1.3 CURRENCY 24
1.4 LIMITATIONS 24
1.5 STAKEHOLDERS 25
2 RESEARCH METHODOLOGY 26
2.1 PRIMARY DATA 27
2.1.1 KEY DATA FROM PRIMARY SOURCES 27
2.1.2 KEY INDUSTRY INSIGHTS 28
2.2 SECONDARY DATA 29
2.2.1 KEY DATA FROM SECONDARY SOURCES 29
2.3 MARKET SIZE ESTIMATION 30
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 32
2.4.1 ASSUMPTIONS FOR THE STUDY 33
3 EXECUTIVE SUMMARY 34
4 PREMIUM INSIGHTS 39
4.1 MOLECULAR DIAGNOSTICS: MARKET OVERVIEW 39
4.2 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY AND REGION, 2018 40
4.3 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE,
2018 VS. 2023 (USD BILLION) 40
4.4 MOLECULAR DIAGNOSTICS MARKET, BY END USER 41
5 MARKET OVERVIEW 42
5.1 INTRODUCTION 42
5.2 MARKET DYNAMICS 42
5.2.1 DRIVERS 43
5.2.1.1 High prevalence of infectious diseases and various types of cancers 43
5.2.1.2 Increasing awareness and acceptance of personalized medicine
and companion diagnostics 43
5.2.1.3 Growth in the biomarker identification market and advancements
in molecular techniques 43
5.2.2 RESTRAINTS 44
5.2.2.1 Complex regulatory frameworks delaying the approval of new molecular diagnostic tests 44
5.2.3 OPPORTUNITIES 44
5.2.3.1 Advances in genomics and proteomics 44
5.2.3.2 Growth opportunities in emerging markets 45
5.2.4 CHALLENGES 46
5.2.4.1 Dearth of trained professionals limiting the appropriate use
of new molecular diagnostic technologies 46
6 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE 47
6.1 INTRODUCTION 48
6.2 REAGENTS & KITS 48
6.3 INSTRUMENTS 51
6.4 SERVICES & SOFTWARE 54
7 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY 58
7.1 INTRODUCTION 59
7.2 POLYMERASE CHAIN REACTION (PCR) 60
7.3 ISOTHERMAL NUCLEIC ACID AMPLIFICATION TECHNOLOGY (INAAT) 63
7.4 DNA SEQUENCING & NEXT-GENERATION SEQUENCING (NGS) 66
7.5 IN SITU HYBRIDIZATION 69
7.6 DNA MICROARRAY 72
7.7 OTHER TECHNOLOGIES 74
8 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION 78
8.1 INTRODUCTION 79
8.2 INFECTIOUS DISEASES 80
8.2.1 HEPATITIS 84
8.2.2 HIV 85
8.2.3 CT/NG 86
8.2.4 HAIS 87
8.2.5 HPV 88
8.2.6 TUBERCULOSIS 89
8.2.7 INFLUENZA 90
8.2.8 OTHER INFECTIOUS DISEASES 91
8.3 ONCOLOGY 92
8.3.1 BREAST CANCER 95
8.3.2 COLORECTAL CANCER 95
8.3.3 LUNG CANCER 96
8.3.4 PROSTATE CANCER 97
8.3.5 OTHER CANCERS 98
8.4 GENETIC TESTS 99
8.5 OTHER APPLICATIONS 102

9 MOLECULAR DIAGNOSTICS MARKET, BY END USER 105
9.1 INTRODUCTION 106
9.2 HOSPITAL & ACADEMIC LABORATORIES 107
9.3 REFERENCE LABORATORIES 110
9.4 OTHER END USERS 113
10 MOLECULAR DIAGNOSTICS MARKET, BY REGION 116
10.1 INTRODUCTION 117
10.2 NORTH AMERICA 118
10.2.1 US 121
10.2.2 CANADA 124
10.3 EUROPE 126
10.3.1 GERMANY 129
10.3.2 FRANCE 132
10.3.3 ITALY 134
10.3.4 SPAIN 136
10.3.5 UK 138
10.3.6 REST OF EUROPE 141
10.4 ASIA PACIFIC 143
10.4.1 JAPAN 147
10.4.2 CHINA 149
10.4.3 AUSTRALIA 152
10.4.4 INDIA 154
10.4.5 ROAPAC 156
10.5 REST OF THE WORLD 159
10.5.1 LATIN AMERICA 161
10.5.1.1 Brazil 163
10.5.1.2 Mexico 166
10.5.1.3 Rest of Latin America 168
10.5.2 MIDDLE EAST & AFRICA 170
11 COMPETITIVE LANDSCAPE 173
11.1 OVERVIEW 173
11.2 MARKET SHARE ANALYSIS 174
11.3 MOLECULAR DIAGNOSTICS MARKET COMPETITIVE SHARE ANALYSIS, BY APPLICATION 175
11.3.1 MARKET SHARE ANALYSIS FOR INFECTIOUS DISEASE APPLICATIONS 175
11.3.2 MOLECULAR DIAGNOSTICS MARKET SHARE ANALYSIS, BY TECHNOLOGY 176
11.3.2.1 POLYMERASE CHAIN REACTION (PCR) 176
11.3.2.2 DNA SEQUENCING AND NGS 176
11.3.2.3 IN SITU HYBRIDIZATION (ISH) 177

11.4 COMPETITIVE SITUATION AND TRENDS 177
11.4.1 NEW PRODUCT LAUNCHES AND APPROVALS, 2016–2018 177
11.4.2 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016–2018 178
11.4.3 ACQUISITIONS AND MERGERS 179
11.4.4 EXPANSIONS 179
12 COMPANY PROFILES 180
Business Overview, Products Offered, Services Offered, Recent Developments, MnM View
12.1 ABBOTT LABORATORIES 180
12.2 AGILENT TECHNOLOGIES 184
12.3 BECTON, DICKINSON AND COMPANY 189
12.4 BIOMÉRIEUX SA 194
12.5 DANAHER CORPORATION 198
12.6 DIASORIN 203
12.7 GRIFOLS 207
12.8 HOLOGIC 210
12.9 ILLUMINA 213
12.10 QIAGEN 217
12.11 ROCHE DIAGNOSTICS 222
12.12 SIEMENS AG 226
12.13 THERMO FISHER SCIENTIFIC 229
*Details might not be captured in case of unlisted companies.
13 APPENDIX 234
13.1 DISCUSSION GUIDE 234
13.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 237
13.3 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE 239
13.4 AVAILABLE CUSTOMIZATIONS 240
13.5 RELATED REPORTS 240
13.6 AUTHOR DETAILS 241

LIST OF TABLES

TABLE 1 NEW TESTS LAUNCHED BY KEY PLAYERS 45
TABLE 2 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 48
TABLE 3 MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION,
2016–2023 (USD MILLION) 48
TABLE 4 NORTH AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 49
TABLE 5 EUROPE: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 49
TABLE 6 ASIA PACIFIC: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 50
TABLE 7 ROW: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET, BY REGION,
2016–2023 (USD MILLION) 50
TABLE 8 LATIN AMERICA: MOLECULAR DIAGNOSTIC REAGENTS & KITS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 50
TABLE 9 MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 51
TABLE 10 NORTH AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 52
TABLE 11 EUROPE: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 52
TABLE 12 ASIA PACIFIC: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 53
TABLE 13 ROW: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET, BY REGION,
2016–2023 (USD MILLION) 53
TABLE 14 LATIN AMERICA: MOLECULAR DIAGNOSTIC INSTRUMENTS MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 53
TABLE 15 MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET, BY REGION,
2016–2023 (USD MILLION) 54
TABLE 16 NORTH AMERICA: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY COUNTRY, 2016–2023 (USD MILLION) 55
TABLE 17 EUROPE: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 55
TABLE 18 ASIA PACIFIC: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 56
TABLE 19 ROW: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY REGION, 2016–2023 (USD MILLION) 56
TABLE 20 LATIN AMERICA: MOLECULAR DIAGNOSTIC SERVICES & SOFTWARE MARKET,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 57
TABLE 21 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 60
TABLE 22 MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY REGION,
2016–2023 (USD MILLION) 61
TABLE 23 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR PCR,
BY COUNTRY, 2016–2023 (USD MILLION) 61
TABLE 24 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 61
TABLE 25 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR PCR,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 62
TABLE 26 ROW: MOLECULAR DIAGNOSTICS MARKET FOR PCR, BY REGION,
2016–2023 (USD MILLION) 62
TABLE 27 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR PCR,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 63
TABLE 28 MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION,
2016–2023 (USD MILLION) 63
TABLE 29 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
BY COUNTRY, 2016–2023 (USD MILLION) 64
TABLE 30 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 64
TABLE 31 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 65
TABLE 32 ROW: MOLECULAR DIAGNOSTICS MARKET FOR INAAT, BY REGION,
2016–2023 (USD MILLION) 65
TABLE 33 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INAAT,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 65
TABLE 34 MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS,
BY REGION, 2016–2023 (USD MILLION) 66
TABLE 35 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA
SEQUENCING AND NGS, BY COUNTRY, 2016–2023 (USD MILLION) 67
TABLE 36 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 67
TABLE 37 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 68
TABLE 38 ROW: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING AND NGS,
BY REGION, 2016–2023 (USD MILLION) 68
TABLE 39 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 68
TABLE 40 MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY REGION, 2016–2023 (USD MILLION) 69
TABLE 41 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY, 2016–2023 (USD MILLION) 70
TABLE 42 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 70
TABLE 43 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 71
TABLE 44 ROW: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION,
BY REGION, 2016–2023 (USD MILLION) 71
TABLE 45 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR IN SITU HYBRIDIZATION, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 71
TABLE 46 MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY REGION,
2016–2023 (USD MILLION) 72
TABLE 47 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY COUNTRY, 2016–2023 (USD MILLION) 72
TABLE 48 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 73
TABLE 49 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 73
TABLE 50 ROW: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY, BY REGION, 2016–2023 (USD MILLION) 74
TABLE 51 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR DNA MICROARRAY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 74
TABLE 52 MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016–2023 (USD MILLION) 75
TABLE 53 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016–2023 (USD MILLION) 75
TABLE 54 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 76
TABLE 55 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 76
TABLE 56 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES,
BY REGION, 2016–2023 (USD MILLION) 77
TABLE 57 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 77
TABLE 58 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 79
TABLE 59 MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,
BY REGION, 2016–2023 (USD MILLION) 80
TABLE 60 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS
DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 81
TABLE 61 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 81
TABLE 62 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 82
TABLE 63 ROW: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES,
BY REGION, 2016–2023 (USD MILLION) 82
TABLE 64 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS
DISEASES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 82
TABLE 65 MOLECULAR DIAGNOSTICS MARKET FOR INFECTIOUS DISEASES, BY DISEASE TYPE, 2016–2023 (USD MILLION) 83
TABLE 66 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 84
TABLE 67 HEPATITIS DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 84
TABLE 68 HIV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 85
TABLE 69 HIV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 85
TABLE 70 CT/NG DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 86
TABLE 71 CT/NG DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 86
TABLE 72 HAI DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 87
TABLE 73 HAI DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 87
TABLE 74 HPV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 88
TABLE 75 HPV DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 88
TABLE 76 TB DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 89
TABLE 77 TB DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 89
TABLE 78 INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 90
TABLE 79 INFLUENZA DIAGNOSTICS MARKET, BY REGION, 2016–2023 (MILLION ASSAYS) 90
TABLE 80 OTHER INFECTIOUS DISEASE DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 91
TABLE 81 MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION,
2016–2023 (USD MILLION) 92
TABLE 82 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY COUNTRY, 2016–2023 (USD MILLION) 92
TABLE 83 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 93
TABLE 84 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 93
TABLE 85 ROW: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY REGION,
2016–2023 (USD MILLION) 94
TABLE 86 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 94
TABLE 87 MOLECULAR DIAGNOSTICS MARKET FOR ONCOLOGY, BY CANCER TYPE,
2016–2023 (USD MILLION) 94
TABLE 88 BREAST CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 95
TABLE 89 COLORECTAL CANCER DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 96
TABLE 90 LUNG CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 96
TABLE 91 PROSTATE CANCER DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 97
TABLE 92 OTHER CANCER DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 98
TABLE 93 MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY REGION,
2016–2023 (USD MILLION) 99
TABLE 94 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY COUNTRY, 2016–2023 (USD MILLION) 99
TABLE 95 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 100
TABLE 96 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 100
TABLE 97 ROW: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING, BY REGION, 2016–2023 (USD MILLION) 101
TABLE 98 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR GENETIC TESTING,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 101
TABLE 99 MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 102
TABLE 100 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2016–2023 (USD MILLION) 102
TABLE 101 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY, 2016–2023 (USD MILLION) 103
TABLE 102 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 103
TABLE 103 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY REGION, 2016–2023 (USD MILLION) 104
TABLE 104 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER APPLICATIONS, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 104
TABLE 105 MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 106
TABLE 106 MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 107
TABLE 107 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL
& ACADEMIC LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION) 108
TABLE 108 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 108
TABLE 109 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 109
TABLE 110 ROW: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY REGION, 2016–2023 (USD MILLION) 109
TABLE 111 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR HOSPITAL & ACADEMIC LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 109
TABLE 112 MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES,
BY REGION, 2016–2023 (USD MILLION) 110
TABLE 113 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016–2023 (USD MILLION) 110
TABLE 114 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 111
TABLE 115 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 111
TABLE 116 ROW: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES,
BY REGION, 2016–2023 (USD MILLION) 112
TABLE 117 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 112
TABLE 118 MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION,
2016–2023 (USD MILLION) 113
TABLE 119 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS,
BY COUNTRY, 2016–2023 (USD MILLION) 113
TABLE 120 EUROPE: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 114
TABLE 121 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 114
TABLE 122 ROW: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2016–2023 (USD MILLION) 115
TABLE 123 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET FOR OTHER END USERS,
BY COUNTRY/REGION, 2016–2023 (USD MILLION) 115
TABLE 124 MOLECULAR DIAGNOSTICS MARKET, BY REGION, 2016–2023 (USD MILLION) 118
TABLE 125 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2016–2023 (USD MILLION) 119
TABLE 126 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 120
TABLE 127 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 120
TABLE 128 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2015–2023 (USD MILLION) 121
TABLE 129 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY,
2016–2023 (USD MILLION) 121
TABLE 130 US: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 122
TABLE 131 US: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 123
TABLE 132 US: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 123
TABLE 133 US: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 123
TABLE 134 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 124
TABLE 135 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 125
TABLE 136 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 125
TABLE 137 CANADA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 126
TABLE 138 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 127
TABLE 139 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 127
TABLE 140 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 128
TABLE 141 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 128
TABLE 142 EUROPE: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 129
TABLE 143 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 130
TABLE 144 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 130
TABLE 145 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 131
TABLE 146 GERMANY: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 131
TABLE 147 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 132
TABLE 148 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 132
TABLE 149 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 133
TABLE 150 FRANCE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 133
TABLE 151 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 134
TABLE 152 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 134
TABLE 153 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 135
TABLE 154 ITALY: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2015–2023 (USD MILLION) 135
TABLE 155 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 136
TABLE 156 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 137
TABLE 157 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 137
TABLE 158 SPAIN: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2015–2023 (USD MILLION) 138
TABLE 159 UK: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2015–2023 (USD MILLION) 139
TABLE 160 UK: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 139
TABLE 161 UK: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 140
TABLE 162 UK: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 140
TABLE 163 ROE: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 141
TABLE 164 ROE: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 141
TABLE 165 ROE: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 142
TABLE 166 ROE: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 142
TABLE 167 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 144
TABLE 168 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 145
TABLE 169 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 145
TABLE 170 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 146
TABLE 171 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION,
2016–2023 (USD MILLION) 146
TABLE 172 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 147
TABLE 173 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 148
TABLE 174 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 148
TABLE 175 JAPAN: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 149
TABLE 176 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 150
TABLE 177 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 150
TABLE 178 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 151
TABLE 179 CHINA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 151
TABLE 180 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 152
TABLE 181 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 152
TABLE 182 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 153
TABLE 183 AUSTRALIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 153
TABLE 184 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 154
TABLE 185 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 155
TABLE 186 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 155
TABLE 187 INDIA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 156
TABLE 188 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 156
TABLE 189 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 157
TABLE 190 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 157
TABLE 191 ROAPAC: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 158
TABLE 192 ROW: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 159
TABLE 193 ROW: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 159
TABLE 194 ROW: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 160
TABLE 195 ROW: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 160
TABLE 196 ROW: MOLECULAR DIAGNOSTICS MARKET, BY REGION,
2016–2023 (USD MILLION) 160
TABLE 197 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2016–2023 (USD MILLION) 161
TABLE 198 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 162
TABLE 199 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 162
TABLE 200 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 163
TABLE 201 LATIN AMERICA: MOLECULAR DIAGNOSTICS MARKET, BY COUNTRY/REGION, 2016–2023 (USD MILLION) 163
TABLE 202 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 164
TABLE 203 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 164
TABLE 204 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 165
TABLE 205 BRAZIL: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 165
TABLE 206 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 166
TABLE 207 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 167
TABLE 208 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 167
TABLE 209 MEXICO: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 168
TABLE 210 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT & SERVICE,
2016–2023 (USD MILLION) 168
TABLE 211 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY,
2016–2023 (USD MILLION) 169
TABLE 212 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION,
2016–2023 (USD MILLION) 169
TABLE 213 ROLA: MOLECULAR DIAGNOSTICS MARKET, BY END USER,
2016–2023 (USD MILLION) 170
TABLE 214 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT
& SERVICE, 2016–2023 (USD MILLION) 170
TABLE 215 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2016–2023 (USD MILLION) 171
TABLE 216 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2016–2023 (USD MILLION) 171
TABLE 217 MIDDLE EAST & AFRICA: MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2016–2023 (USD MILLION) 172
TABLE 218 NEW PRODUCT LAUNCHES AND APPROVALS, 2016–2018 177
TABLE 219 AGREEMENTS, PARTNERSHIPS, AND COLLABORATIONS, 2016–2018 178
TABLE 220 ACQUISITIONS AND MERGERS 2016–2018 179
TABLE 221 EXPANSIONS, 2016–2018 179


LIST OF FIGURES

FIGURE 1 RESEARCH DESIGN 26
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 29
FIGURE 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH 31
FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 31
FIGURE 5 DATA TRIANGULATION 32
FIGURE 6 MOLECULAR DIAGNOSTICS MARKET, BY PRODUCT AND SERVICE, 2018 VS. 2023 34
FIGURE 7 MOLECULAR DIAGNOSTICS MARKET, BY APPLICATION, 2018 VS. 2023 35
FIGURE 8 MOLECULAR DIAGNOSTICS MARKET, BY TECHNOLOGY, 2018 VS. 2023 36
FIGURE 9 MOLECULAR DIAGNOSTICS MARKET, BY END USER, 2018 VS. 2023 37
FIGURE 10 GEOGRAPHICAL SNAPSHOT OF THE MOLECULAR DIAGNOSTICS MARKET 38
FIGURE 11 INCREASING PREVALENCE OF INFECTIOUS DISEASES AND VARIOUS TYPES
OF CANCERS — KEY DRIVERS FOR THE MARKET 39
FIGURE 12 PCR TECHNOLOGY TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2018 40
FIGURE 13 REAGENTS AND KITS TO DOMINATE THE MOLECULAR DIAGNOSTICS MARKET
IN 2023 40
FIGURE 14 HOSPITAL AND ACADEMIC LABORATORIES TO ACCOUNT FOR THE LARGEST
SHARE IN 2018 41
FIGURE 15 MOLECULAR DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES,
AND CHALLENGES 42
FIGURE 16 DNA SEQUENCING & NGS TO WITNESS THE HIGHEST GROWTH DURING
THE FORECAST PERIOD (2018–2023) 59
FIGURE 17 GEOGRAPHICAL SNAPSHOT: ASIA PACIFIC TO BE THE FASTEST-GROWING REGIONAL SEGMENT IN THE MOLECULAR DIAGNOSTICS MARKET 117
FIGURE 18 NORTH AMERICA: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 119
FIGURE 19 ASIA PACIFIC: MOLECULAR DIAGNOSTICS MARKET SNAPSHOT 144
FIGURE 20 COMPANIES ADOPTED PRODUCT LAUNCHES AS THEIR KEY GROWTH STRATEGY OVER THE LAST THREE YEARS 173
FIGURE 21 GLOBAL MOLECULAR DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2017 174
FIGURE 22 GLOBAL INFECTIOUS DISEASE DIAGNOSTICS MARKET RANKING, BY KEY
PLAYER, 2017 175
FIGURE 23 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR PCR, MARKET SHARE
ANALYSIS, BY KEY PLAYER 2016 176
FIGURE 24 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR DNA SEQUENCING
AND NGS, MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016 176
FIGURE 25 GLOBAL MOLECULAR DIAGNOSTICS MARKET FOR ISH, BY KEY PLAYER, 2016 177
FIGURE 26 ABBOTT LABORATORIES: COMPANY SNAPSHOT 180
FIGURE 27 AGILENT TECHNOLOGIES: COMPANY SNAPSHOT 184
FIGURE 28 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 189
FIGURE 29 BIOMÉRIEUX SA: COMPANY SNAPSHOT 194
FIGURE 30 DANAHER CORPORATION: COMPANY SNAPSHOT 198
FIGURE 31 DIASORIN: COMPANY SNAPSHOT 203

FIGURE 32 GRIFOLS: COMPANY SNAPSHOT 207
FIGURE 33 HOLOGIC: COMPANY SNAPSHOT 210
FIGURE 34 ILLUMINA: COMPANY SNAPSHOT 213
FIGURE 35 QIAGEN: COMPANY SNAPSHOT (2017) 217
FIGURE 36 ROCHE DIAGNOSTICS: COMPANY SNAPSHOT 222
FIGURE 37 SIEMENS AG: COMPANY SNAPSHOT 226
FIGURE 38 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT 229


【レポートのキーワード】

分子診断、感染症診断、がん診断、遺伝子検査、分子診断技術、分子診断試薬

★調査レポート[分子診断の世界市場予測(~2023年)] ( Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023 / MD2521) 販売に関する免責事項
[分子診断の世界市場予測(~2023年)] ( Molecular Diagnostics Market by Application (Infectious Disease (Hepatitis, HIV), Oncology, Genetic Testing), Technology (PCR, DNA Sequencing & NGS), End User (Hospital/Academic Laboratory), Product & Service (Reagent, Software) - Global Forecast to 2023 / MD2521) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆